Maintaining proper fluid intake, especially during GLP-1 therapy when gastrointestinal symptoms may affect hydration status, is important for cognitive performance
It can be estimated that loss of 6 kg LM associated with incretin therapies approximates the impact of a decade or more of human ageing on skeletal muscle mass In general, to fight the loss of lean muscle mass, one can add resistance training and a high protein diet
Its molecular structure: Approximately 39 amino acids Synthetic, manufactured via Solid-Phase Peptide Synthesis Fatty acid-conjugated for extended biological half-life Rationally designed for balanced activation across GLP-1, GIP, and glucagon receptors The Phase 2 clinical trial data, published in the New England Journal of Medicine in 2023, reported substantial metabolic effects that exceeded what previous-generation single and dual agonists had produced
TRIUMPH-4 ran 68 weeks of continuous dosing under clinical supervision
Wang XF, Liu JJ, Xia J, Liu J, Mirabella V, Pang ZP